Here, we have increased the sample size of our CSF-published studies to 3107 individuals and focused on the LRRK2 locus to resolve the most significant locus for PD risk and elucidate the downstream mechanism of LRRK2 common variants. The gene discussed is LRRK2; the disease is Parkinson disease.